Category: Cephalon

  • EU fines Teva and Cephalon €60.5m for ‘pay for delay’ scheme

    The European Union has fined Teva and its neurology unit Cephalon €60.5 million for an elaborate “pay for delay” scheme that prevented cheaper generic competition for its sleep disorder drug Provigil (modafinil).  In a statement the EU said the scheme prevented generic competition for Provigil, which is used to treat narcolepsy, after its main patents […]